PROMETRA II Programmable Infusion Pump, Implantable Infusion Pump, Catalog Number/REF 13827, Part Number PL-31790-02. Manufactured by: Flowonix Medical Inc., --- The correction involves the labeling of the device plus the following Prometra II pump labeling is also being revised: Intrathecal Catheter IFU, REF 11823, PL-22790-02; Catheter Revision Kit IFU, REF 11 830, PL-21798-02; Refill Kit IFU, REF 11825, PL-21794-00; Prometra II Patient Implant Card (Permanent) PL-32300-01; Prometra II Patient Implant Card (Temporary): PL-32375-01; Prometra II Patient Guide: PL-31912-01. The Prometra Programmable Infusion Pump System is indicated for intrathecal infusion of Infumorph (preservative-free morphine sulfate sterile solution) or preservative-free sterile 0.9% saline solution (sodium chloride injection, USP).
Publicado el 26 de julio de 2017 · Inicio del retiro: 22 de mayo de 2017
Resumen
FDA registra el retiro Z-2740-2017 de dispositivos médicos de Clase II, publicado el 26 de julio de 2017 e iniciado el 22 de mayo de 2017. Empresa responsable: Flowonix Medical, Inc.; Estado: Finalizado; Cantidad reportada: US: 2204 units; Lote: All. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Flowonix Medical received a report of a patient implanted with the Prometra II Programmable Pump who may have received a fatal drug overdose during an MRI procedure. The Prometra II pump has an FDA-approved design feature intended to permit safe exposure to an MRI without removing drug from the reservoir.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Flowonix Medical, Inc.
- Distribuidor
- Nationwide Distribution
- Lote
- All
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAAgfa Healthcare NX 3.0.8950 Imaging Processing Software26 de julio de 2017
- FDAMAKO RIO Standard System, internal cPCI Card CageP/N: 201337. Intended to assist the surgeon in providing26 de julio de 2017
- FDAPenumbra 3D Revascularization Device It is indicated for used in the revascularization of patients with acute26 de julio de 2017
- FDA7245C, 7245C/E, 7245D Computer Digital Video System Product Usage: The 7245C, 7245C/E and 7245D are used to26 de julio de 2017
- FDAStandex International Bakers Pride Microwave Ovens Model E30026 de julio de 2017
- FDA9400 Laryngeal Strobe Product Usage: The 9310HD is used to electronically record, display, transfer, and store26 de julio de 2017
Preguntas sobre este retiro
¿PROMETRA II Programmable Infusion Pump, Implantable Infusion Pump, Catalog Number/REF 13827, Part Number PL-31790-02. Manufactured by: Flowonix Medical Inc., --- The correction involves the labeling of the device plus the following Prometra II pump labeling is also being revised: Intrathecal Catheter IFU, REF 11823, PL-22790-02; Catheter Revision Kit IFU, REF 11 830, PL-21798-02; Refill Kit IFU, REF 11825, PL-21794-00; Prometra II Patient Implant Card (Permanent) PL-32300-01; Prometra II Patient Implant Card (Temporary): PL-32375-01; Prometra II Patient Guide: PL-31912-01. The Prometra Programmable Infusion Pump System is indicated for intrathecal infusion of Infumorph (preservative-free morphine sulfate sterile solution) or preservative-free sterile 0.9% saline solution (sodium chloride injection, USP). fue retirado del mercado?
Sí. FDA publicó el retiro Z-2740-2017 el 26 de julio de 2017. Peligro reportado: Flowonix Medical received a report of a patient implanted with the Prometra II Programmable Pump who may have received a fatal drug overdose during an MRI procedure. The Prometra II pump has an FDA-approved design feature intended to permit safe exposure to an MRI without removing drug from the reservoir.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter